Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.

Belser JA, Szretter KJ, Katz JM, Tumpey TM.

Virology. 2013 Apr 25;439(1):42-6. doi: 10.1016/j.virol.2013.01.017. Epub 2013 Mar 1.

2.

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA.

Antivir Ther. 2007;12(3):363-70.

PMID:
17591026
3.

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

Kumaki Y, Day CW, Smee DF, Morrey JD, Barnard DL.

Antiviral Res. 2011 Nov;92(2):329-40. doi: 10.1016/j.antiviral.2011.09.001. Epub 2011 Sep 8.

4.

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.

Ilyushina NA, Hay A, Yilmaz N, Boon AC, Webster RG, Govorkova EA.

Antimicrob Agents Chemother. 2008 Nov;52(11):3889-97. doi: 10.1128/AAC.01579-07. Epub 2008 Aug 25.

5.

Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.

Simeonova L, Gegova G, Galabov AS.

Antiviral Res. 2012 Aug;95(2):172-81. doi: 10.1016/j.antiviral.2012.05.004. Epub 2012 May 19.

PMID:
22617756
6.

Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.

Kiso M, Kubo S, Ozawa M, Le QM, Nidom CA, Yamashita M, Kawaoka Y.

PLoS Pathog. 2010 Feb 26;6(2):e1000786. doi: 10.1371/journal.ppat.1000786.

7.

Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.

Pizzorno A, Abed Y, Rhéaume C, Boivin G.

Antiviral Res. 2014 May;105:54-8. doi: 10.1016/j.antiviral.2014.02.017. Epub 2014 Feb 28.

PMID:
24583158
8.

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.

Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O.

Antiviral Res. 2011 Sep;91(3):304-13. doi: 10.1016/j.antiviral.2011.07.006. Epub 2011 Jul 13.

PMID:
21777621
9.

[Efficacy of combined administration of ridostin and oseltamivir (tamiflu) for therapy and prophylaxis of experimental infection induced by influenza virus A (H5N1) in mice].

Skarnovich MO, Shishkina LN, Kabanov AS, Mazurkova NA, Danilenko ED, Masycheva VI, Drozdov IG.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Sep-Oct;(5):79-82. Russian.

PMID:
22145356
10.

Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.

Julander JG, Hagloch J, Latimer S, Motter N, Dagley A, Barnard DL, Smee DF, Morrey JD.

Antiviral Res. 2011 Nov;92(2):228-36. doi: 10.1016/j.antiviral.2011.08.011. Epub 2011 Aug 17.

PMID:
21867731
11.

Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.

Onishi M, Kitano M, Taniguchi K, Homma T, Kobayashi M, Yoshinaga T, Naito A, Sato A.

Antiviral Res. 2015 May;117:52-9. doi: 10.1016/j.antiviral.2015.02.012. Epub 2015 Mar 6.

PMID:
25752738
12.

Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice.

Perrone LA, Belser JA, Wadford DA, Katz JM, Tumpey TM.

J Infect Dis. 2013 May 15;207(10):1576-84. doi: 10.1093/infdis/jit062. Epub 2013 Feb 18.

PMID:
23420903
13.

Combined administration of oseltamivir and hochu-ekki-to (TJ-41) dramatically decreases the viral load in lungs of senescence-accelerated mice during influenza virus infection.

Ohgitani E, Kita M, Mazda O, Imanishi J.

Arch Virol. 2014 Feb;159(2):267-75. doi: 10.1007/s00705-013-1807-3. Epub 2013 Aug 25.

PMID:
23979178
14.

Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.

Smee DF, Hurst BL, Wong MH, Bailey KW, Morrey JD.

Antimicrob Agents Chemother. 2009 May;53(5):2120-8. doi: 10.1128/AAC.01012-08. Epub 2009 Mar 9.

15.

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.

Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT.

PLoS One. 2012;7(1):e31006. doi: 10.1371/journal.pone.0031006. Epub 2012 Jan 23.

16.

Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.

Liu Z, Guo Z, Wang G, Zhang D, He H, Li G, Liu Y, Higgins D, Walsh A, Shanahan-Prendergast L, Lu J.

Eur J Pharm Sci. 2009 Oct 8;38(3):215-23. doi: 10.1016/j.ejps.2009.07.004. Epub 2009 Jul 16.

PMID:
19616097
17.

Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model.

Boltz DA, Rehg JE, McClaren J, Webster RG, Govorkova EA.

J Infect Dis. 2008 May 1;197(9):1315-23. doi: 10.1086/586711.

PMID:
18422444
18.

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus.

Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ, Chen HL, Wong SS, Lau SK, Woo PC, Chan KH, Jin DY, Yuen KY.

Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8091-6. doi: 10.1073/pnas.0711942105. Epub 2008 Jun 3.

19.

Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.

Van Hoeven N, Belser JA, Szretter KJ, Zeng H, Staeheli P, Swayne DE, Katz JM, Tumpey TM.

J Virol. 2009 Apr;83(7):2851-61. doi: 10.1128/JVI.02174-08. Epub 2009 Jan 14.

20.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296

Supplemental Content

Support Center